This is the authors' abstract. We don't add key points for this paper.
Combined DTI and serum NFL measurements may enhance the evaluation of axonal injury in MS by providing complementary in vivo and biochemical perspectives. The corresponding changes observed between the modalities support their utility as non-invasive biomarkers reflecting pathophysiological processes and clinical status in MS. Larger validation cohorts are needed to determine the clinical applicability.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Jalilian et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: